PHARMERICA (DOSE) - Undervalued Growth Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PHARMERICA (DOSE) - Undervalued Growth Company

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rob Anderson who wrote (5)	11/4/1998 9:43:00 AM
From: jimiboy	Read Replies (1) of 24

My personal experience with DOSE has been a little rough. I bought at 11, talked myself out of selling at 16, and purchased some more just below 5. This stock has been brought to me by 3 different cold callers in the last 3 mos. It has been "can't miss" for a long time. I think we fool ourselves if we think we have equal resources to the big players. The amount of large blocks that got out the two weeks before the Beverly Enterprises bad news should be ample proof that the game is fixed. Hey I love DOSE. I think DOSE is a great value. I love the concept of buying bulk tablets for a nickel and dispensing them for a buck. This company has so many acquisitions that I can't conceive of an accurate Income Statement being possible. This stock will go up when the institutions, after their own review, decide the company has their operations in a satisfactory situation. The Market is an amazing thing, and generally does a better job at valuation than we think. It always scares me when I pick-up undervalued shares that someone who knows probably more than me sold'em.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next